Boston Provident’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-83,028
Closed -$2.01M 35
2015
Q1
$2.01M Sell
83,028
-43,190
-34% -$1.1M 0.95% 26
2014
Q4
$3.09M Buy
126,218
+164
+0.1% +$3.82K 0.88% 26
2014
Q3
$2.79M Sell
126,054
-169,373
-57% -$3.99M 0.58% 27
2014
Q2
$8.07M Sell
295,427
-80,801
-21% -$2.34M 1.72% 13
2014
Q1
$11.7M Sell
376,228
-73,189
-16% -$2.02M 4.17% 7
2013
Q4
$11M Sell
449,417
-124,761
-22% -$2.61M 5.12% 5
2013
Q3
$10.4M Buy
+574,178
New +$13.1M 2.84% 8

Other funds holding OSG

Boston Provident's OSG Position: Q2 2015 in Review

Boston Provident sold out of Octave Specialty Group (OSG) in Q2 2015, closing a stake of 83,028 shares — an estimated $2.01M sold.

Boston Provident first reported a position in OSG in Q3 2013 and held it in 7 quarters. The position peaked at $11.7M in Q1 2014. 125 funds tracked by Wall St. Rank hold OSG as of Q2 2015.

  • Boston Provident reported no remaining Octave Specialty Group position as of Q2 2015 after selling out during the quarter.
  • Boston Provident sold 83,028 Octave Specialty Group shares in Q2 2015, an estimated $2.01M.
  • Boston Provident first reported a position in Octave Specialty Group in Q3 2013 and held it in 7 quarters.
  • Boston Provident's Octave Specialty Group position peaked at $11.7M in Q1 2014.
  • 125 funds tracked by Wall St. Rank held Octave Specialty Group as of Q2 2015.

Based on Boston Provident's 13F filing for Q2 2015, filed 14 Aug 2015.